VLKIM
ABBV icon

Van Lanschot Kempen Investment Management’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.1M Buy
54,423
+16,292
+43% +$3.02M 0.1% 152
2025
Q1
$7.99M Buy
38,131
+1,652
+5% +$346K 0.08% 159
2024
Q4
$6.48M Sell
36,479
-459
-1% -$81.6K 0.06% 162
2024
Q3
$7.29M Sell
36,938
-636
-2% -$126K 0.07% 147
2024
Q2
$6.44M Buy
37,574
+5,073
+16% +$870K 0.07% 149
2024
Q1
$5.92M Buy
32,501
+7,369
+29% +$1.34M 0.07% 151
2023
Q4
$3.89M Buy
25,132
+3,041
+14% +$471K 0.05% 158
2023
Q3
$3.29M Buy
22,091
+20,175
+1,053% +$3.01M 0.06% 138
2023
Q2
$258K Buy
+1,916
New +$258K ﹤0.01% 188
2021
Q2
Sell
-17,941
Closed -$1.94M 203
2021
Q1
$1.94M Buy
17,941
+2,385
+15% +$258K 0.09% 123
2020
Q4
$1.67M Sell
15,556
-4,840
-24% -$519K 0.1% 123
2020
Q3
$1.79M Buy
20,396
+1,005
+5% +$88K 0.14% 107
2020
Q2
$1.9M Buy
19,391
+4,724
+32% +$464K 0.14% 106
2020
Q1
$1.12M Buy
14,667
+845
+6% +$64.4K 0.09% 119
2019
Q4
$1.22M Buy
13,822
+13,253
+2,329% +$1.17M 0.08% 128
2019
Q3
$43K Hold
569
﹤0.01% 170
2019
Q2
$41K Buy
+569
New +$41K ﹤0.01% 174
2017
Q4
Sell
-316,850
Closed -$28.2M 156
2017
Q3
$28.2M Sell
316,850
-13,050
-4% -$1.16M 2.18% 6
2017
Q2
$23.9M Sell
329,900
-34,800
-10% -$2.52M 2.26% 14
2017
Q1
$23.8M Buy
364,700
+22,400
+7% +$1.46M 2.74% 13
2016
Q4
$21.4M Buy
342,300
+26,950
+9% +$1.69M 2.68% 13
2016
Q3
$19.9M Buy
+315,350
New +$19.9M 2.58% 17
2015
Q4
Sell
-19,200
Closed -$1.05M 140
2015
Q3
$1.05M Sell
19,200
-2,000
-9% -$109K 0.13% 88
2015
Q2
$1.42M Buy
21,200
+3,000
+16% +$202K 0.16% 71
2015
Q1
$1.07M Buy
+18,200
New +$1.07M 0.13% 76
2014
Q4
Sell
-572,192
Closed -$33.1M 134
2014
Q3
$33.1M Sell
572,192
-82,100
-13% -$4.74M 3.45% 11
2014
Q2
$36.9M Buy
+654,292
New +$36.9M 3.58% 8